Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)

Last updated: January 6, 2026
Sponsor: Merck Sharp & Dohme LLC
Overall Status: Completed

Phase

2

Condition

Hiv

Treatment

Placebo to MK-8527

MK-8527

Clinical Study ID

NCT06045507
8527-007
  • Ages 18-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This double-blind, placebo-controlled study was designed to assess the safety, tolerability, and pharmacokinetics of oral MK-8527 taken once monthly (QM) in participants at low risk for human immunodeficiency virus Type 1 (HIV-1) infection.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Is confirmed HIV-uninfected based on negative HIV-1/HIV-2 test result beforerandomization

  • Has low-risk of HIV infection

  • Females: is not pregnant or breastfeeding and is either not a participant ofchildbearing potential (POCBP) OR is a POCBP and uses an acceptable contraception oris abstinent from penile-vaginal intercourse

Exclusion

Exclusion Criteria:

  • Has hypersensitivity or other contraindication to any of the components of the studyinterventions as determined by the investigator

  • Has an active diagnosis of hepatitis due to any cause, including active hepatitis B (HBV) infection (defined as HBsAg-positive) or hepatitis C virus (HCV) infection (defined as detectable HCV ribonucleic acid [RNA])

  • Prior use of MK-8527 or islatravir (MK-8591)

Study Design

Total Participants: 352
Treatment Group(s): 2
Primary Treatment: Placebo to MK-8527
Phase: 2
Study Start date:
November 08, 2023
Estimated Completion Date:
February 12, 2025

Connect with a study center

  • Rambam Health Care Campus ( Site 0003)

    Haifa, 3109601
    Israel

    Site Not Available

  • Rambam Health Care Campus ( Site 0003)

    Haifa 294801, 3109601
    Israel

    Site Not Available

  • Hadassah Medical Center ( Site 0002)

    Jerusalem, 9112001
    Israel

    Site Not Available

  • Hadassah Medical Center ( Site 0002)

    Jerusalem 281184, 9112001
    Israel

    Site Not Available

  • Sheba Medical Center ( Site 0001)

    Ramat Gan, 5265601
    Israel

    Site Not Available

  • Sheba Medical Center ( Site 0001)

    Ramat Gan 293788, 5265601
    Israel

    Site Not Available

  • Josha Research ( Site 0023)

    Bloemfontein, Free State 9301
    South Africa

    Site Not Available

  • Josha Research ( Site 0023)

    Bloemfontein 1018725, Free State 967573 9301
    South Africa

    Site Not Available

  • Helen Joseph Hospital ( Site 0024)

    Johannesburg, Gauteng 2092
    South Africa

    Site Not Available

  • Wits RHI-Wits RHI Ward 21 Clinical Research site ( Site 0027)

    Johannesburg, Gauteng 2000
    South Africa

    Site Not Available

  • Helen Joseph Hospital ( Site 0024)

    Johannesburg 993800, Gauteng 1085594 2092
    South Africa

    Site Not Available

  • Wits RHI-Wits RHI Ward 21 Clinical Research site ( Site 0027)

    Johannesburg 993800, Gauteng 1085594 2000
    South Africa

    Site Not Available

  • Qhakaza Mbokodo Research Clinic ( Site 0026)

    Ladysmith 984998, KwaZulu-Natal 972062 3370
    South Africa

    Site Not Available

  • Qhakaza Mbokodo Research Clinic ( Site 0026)

    Ladysmith, Kwazulu-Natal 3370
    South Africa

    Site Not Available

  • Desmond Tutu Health Foundation ( Site 0021)

    Cape Town, Western Cape 7925
    South Africa

    Site Not Available

  • Desmond Tutu Health Foundation ( Site 0021)

    Cape Town 3369157, Western Cape 1085599 7925
    South Africa

    Site Not Available

  • Velocity Clinical Research, North Hollywood ( Site 0054)

    North Hollywood, California 91606
    United States

    Site Not Available

  • Bridge HIV- San Francisco Department of Public Health ( Site 0042)

    San Francisco, California 94102
    United States

    Site Not Available

  • Velocity Clinical Research, North Hollywood ( Site 0054)

    North Hollywood 5377654, California 5332921 91606
    United States

    Site Not Available

  • Bridge HIV- San Francisco Department of Public Health ( Site 0042)

    San Francisco 5391959, California 5332921 94102
    United States

    Site Not Available

  • Velocity Clinical Research, Hallandale Beach ( Site 0052)

    Hallandale Beach, Florida 33009
    United States

    Site Not Available

  • Community Medical Care Center ( Site 0056)

    Immokalee, Florida 34142
    United States

    Site Not Available

  • Velocity Clinical Research, Hallandale Beach ( Site 0052)

    Hallandale 4157898, Florida 4155751 33009
    United States

    Site Not Available

  • Community Medical Care Center ( Site 0056)

    Immokalee 4159553, Florida 4155751 34142
    United States

    Site Not Available

  • Velocity Clinical Research Rockville ( Site 0048)

    Rockville, Maryland 20854
    United States

    Site Not Available

  • Velocity Clinical Research, Rockville ( Site 0048)

    Rockville, Maryland 20854
    United States

    Active - Recruiting

  • Velocity Clinical Research Rockville ( Site 0048)

    Rockville 4367175, Maryland 4361885 20854
    United States

    Site Not Available

  • Fenway Health ( Site 0043)

    Boston, Massachusetts 02215
    United States

    Site Not Available

  • Fenway Health ( Site 0043)

    Boston 4930956, Massachusetts 6254926 02215
    United States

    Site Not Available

  • Albuquerque Clinical Trials, Inc. ( Site 0044)

    Albuquerque, New Mexico 87102
    United States

    Site Not Available

  • Albuquerque Clinical Trials, Inc. ( Site 0044)

    Albuquerque 5454711, New Mexico 5481136 87102
    United States

    Site Not Available

  • University of Pittsburgh Medical Center-Division of Infectious Diseases ( Site 0041)

    Pittsburgh, Pennsylvania 15213
    United States

    Site Not Available

  • University of Pittsburgh Medical Center-Division of Infectious Diseases ( Site 0041)

    Pittsburgh 5206379, Pennsylvania 6254927 15213
    United States

    Site Not Available

  • Prism Health North Texas, Oak Cliff Health Center ( Site 0045)

    Dallas, Texas 75208
    United States

    Site Not Available

  • Prism Health North Texas, Oak Cliff Health Center ( Site 0045)

    Dallas 4684888, Texas 4736286 75208
    United States

    Site Not Available

  • Fred Hutchinson Cancer Center - The Seattle HIV Vaccine Trials Unit ( Site 0057)

    Seattle, Washington 98104
    United States

    Site Not Available

  • Fred Hutchinson Cancer Center - The Seattle HIV Vaccine Trials Unit ( Site 0057)

    Seattle 5809844, Washington 5815135 98104
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.